HHS - adult (JBDS protocol)
Bedside summary
Hyperosmolar hyperglycaemic state per JBDS: marked hypovolaemia and hyperglycaemia (usually >=30 mmol/L) WITHOUT significant ketonaemia (<3 mmol/L) or acidosis (pH >7.3, bicarbonate >15), with raised osmolality (often >=320 mosmol/kg; calculated as 2xNa + glucose + urea). It evolves over days, carries a high mortality and a high thrombosis risk, and fluid - not insulin - is the priority.
Assessment
Investigations
- Calculate osmolality (2 x Na + glucose + urea); glucose, ketones, VBG
- U&E, FBC, CRP, cultures; ECG, troponin
- Identify the precipitant (infection, MI, drugs, dehydration)
- Assess for thrombosis and the degree of hypovolaemia
Management
- Fluid is the mainstay: 0.9% sodium chloride - it alone lowers glucose and osmolality
- Aim a positive balance of about 3-6 L by 12 h (total replacement of estimated losses ~100-220 mL/kg) - rate slower in the frail/cardiac/renal
- Goal: fall in glucose NO faster than 5 mmol/L/h; osmolality fall about 3-8 mosmol/kg/h (avoid rapid shifts)
- Sodium may rise initially - this is acceptable if osmolality is falling; switch to 0.45% saline only if osmolality is not falling despite adequate positive balance
- Insulin: do NOT start at the outset. Start low-dose FRIII at 0.05 units/kg/h ONLY if there is significant ketonaemia (mixed DKA/HHS) or once glucose stops falling with fluids alone
- Potassium replacement guided by levels (as for DKA)
- Target glucose 10-15 mmol/L in the first 24 h; full biochemical recovery may take up to 72 h
- VTE prophylaxis with LMWH for ALL patients (very high thrombotic risk) unless contraindicated
- Foot and pressure-area protection; treat the precipitant; involve the diabetes team
- Watch for fluid overload, central pontine myelinolysis (over-rapid correction) and arterial/venous thrombosis
Drugs & doses
Disposition
In HHS fluids do the work and insulin comes later and low-dose - drop glucose by no more than 5 mmol/L/h and anticoagulate everyone.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.